Infection with a common virus may increase the risk of Type 2 diabetes in older adults, a new study from the Netherlands suggests. In the study, adults ages 85 and over who were infected with ...

Early interim data show Cytomegalovirus (CMV)-negative kidney transplant recipients vaccinated with three doses of HB-101 had reduced incidence of CMV viremia, reduced antiviral use and no CMV disease ...

CMV is the most common infectious cause of birth defects in the U.S.; there is no approved vaccine to prevent CMV CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Moderna, Inc., (Nasdaq: MRNA) a clinical stage ...

Phase 2 study to confirm dose to be initiated in near term, with planned interim analysis through 3 months; Phase 3 study planning is underway CMV is the most common infectious cause of birth defects ...

Renal cytomegalovirus infection may precipitate or worsen anemia in patients with chronic kidney disease, according to recent findings. Previous studies have associated the development of anemia with ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of ...

Pune, Maharashtra, India, October 19 2022 (Wiredrelease) Prudour Pvt. Ltd –:The cytomegalovirus therapeutics market was valued at USD 873.10 million in 2019 and is expected to reach USD 1,013.2 ...

Immunity against cytomegalovirus (CMV) is initiated after its recognition by Toll-like receptor 2 (TLR2). We assessed the association between a single-nucleotide polymorphism (SNP) that impairs TLR2 ...

The novel coronavirus is not only known for causing mild to severe infections, but is also efficient in leaving a post COVID effect. As per reports, five cases of Cytomegalovirus (CMV), leading to ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of ...